COMMUNIQUÉS West-GlobeNewswire

PharmaCorp Announces C$15 Million Bought Deal Public Offering
05/11/2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE [...]
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
05/11/2025
MELVILLE, N.Y., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
STERIS Announces Financial Results for Fiscal 2026 Second Quarter
05/11/2025
Total revenue from continuing operations increased 10%; constant currency organic revenue grew 9% As reported EPS from continuing operations increased to $1.94; adjusted EPS increased to $2.47 Fiscal 2026 constant [...]
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
05/11/2025
Unlike many other diseases, there are no set guidelines on treatment targets for obesity, and outcomes often rely on percentage weight loss only Body mass index (BMI) and waist-to-height ratio (a measurement of [...]
Benitec Biopharma Inc. Announces Proposed Public Offering
05/11/2025
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines [...]
Tarsus to Participate in Upcoming Investor Conference
05/11/2025
IRVINE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in a fireside chat at the Guggenheim 2 nd Annual Healthcare Innovation [...]
LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quarter 2025 earnings [...]
UPDATE - MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]
Genmab to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference in London
05/11/2025
Media Release COPENHAGEN, Denmark; November 5, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its Chief Executive Officer Jan Van de Winkel and C hief F inancial O fficer Anthony Pagano will participate in a [...]
Emerald Heights Social Accountability Committee Donates $305,000 to Support 15 Charities Benefiting Local Communities
05/11/2025
REDMOND, Wash., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Emerald Heights, a leading nonprofit senior living community, proudly announces a donation of $305,000 to 15 local charities through its Social Accountability Committee [...]
FDA Warns Companies Over Illegal Marketing of Botox and Related Products
05/11/2025
Silver Spring, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, [...]
Alpha Pro Tech, Ltd. Announces Third Quarter 2025 Financial Results
05/11/2025
Overall Third Quarter Sales Increased 3.7% to $14.8 Million, Compared to $14.3 Million for the Third Quarter of 2024 Net sales for the third quarter of 2025 were $14.8 million, up 3.7% compared to $14.3 million for the [...]
CJ Biomaterials signs partnership with BIQ Materials to produce artificial turf infill made with PHACT™ PHA, a certified biodegradable biopolymer, for the European market
05/11/2025
CJ Biomaterials signed an agreement with BIQ Materials, a Swedish biomaterials compounding company, to accelerate the commercialization of PHACT™ PHA-based infill EU ban on intentionally added microplastics including [...]
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
05/11/2025
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade [...]
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and [...]
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
05/11/2025
VERO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies and innovative treatments [...]
Mucinex Brings Mr. Mucus to Canada for the First Time With Proven 12-Hour Cold and Flu Relief
05/11/2025
The germ-loving, cult-favourite Mucinex mascot Mr. Mucus makes his Canadian debut in a coast-to-coast campaign challenging Canadians to kick this seasonal nuisance to the curb TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- [...]
Ambio Life Sciences Launches Europe’s First Physician-Led Ibogaine Clinic
05/11/2025
With the opening of its new clinic on Malta’s scenic Mellieha Bay, Ambio becomes the only transcontinental ibogaine provider in the world The clinic responds to high global demand for safe ibogaine treatment with added [...]
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
05/11/2025
First-of-its-kind study represents the potential for robotic-enabled microsurgical intervention for neurodegenerative diseases, including Alzheimer’s JACKSONVILLE, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MMI (Medical [...]

Pages